UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000004296
Receipt No. R000005134
Scientific Title A phase II trial of gefitinib in combination with bevacizumab as first line therapy for advanced non-small-cell lung cancer with mutated EGFR
Date of disclosure of the study information 2010/10/01
Last modified on 2012/10/17 19:11:33

No. Disposal Last modified on Item of update
1 Insert 2010/09/29 21:53:34
2 Update 2010/10/01 18:08:18 Recruitment status
3 Update 2012/10/17 19:09:58 Post marketing survey by drug manufacture etc., specified by Japanese law.
4 Update 2012/10/17 19:11:33 Recruitment status

Contact us.